Menu
Back to User profile » Dr Alberto Bongiovanni
Papers published by Dr Alberto Bongiovanni:
Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas
Recine F, Bongiovanni A, Riva N, Fausti V, De Vita A, Mercatali L, Liverani C, Miserocchi G, Amadori D, Ibrahim T
OncoTargets and Therapy 2017, 10:1155-1164
Published Date: 23 February 2017
Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: efficacy profile, safety, and quality of life
Severi S, Grassi I, Nicolini S, Sansovini M, Bongiovanni A, Paganelli G
OncoTargets and Therapy 2017, 10:551-557
Published Date: 27 January 2017
Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas
De Vita A, Mercatali L, Recine F, Pieri F, Riva N, Bongiovanni A, Liverani C, Spadazzi C, Miserocchi G, Amadori D, Ibrahim T
OncoTargets and Therapy 2016, 9:6233-6246
Published Date: 11 October 2016
First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma
Bongiovanni A, Riva N, Ricci M, Liverani C, La Manna F, De Vita A, Foca F, Mercatali L, Severi S, Amadori D, Ibrahim T
OncoTargets and Therapy 2015, 8:3613-3619
Published Date: 3 December 2015
Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature
Bongiovanni A, Riva N, Calpona S, Ricci M, Gunelli E, Liverani C, La Manna F, De Vita A, Monti M, Severi S, Pieri F, Amadori E, Galassi R, Cavaliere D, Zaccaroni A, Tartaglia A, Lunedei V, Gardini A, Mercatali L, Amadori D, Ibrahim T
OncoTargets and Therapy 2014, 7:1919-1926
Published Date: 20 October 2014